Abstract PO3-13-09: Personalized ctDNA testing for detection of molecular residual disease in patients with localized HR+ breast cancer: temporal dynamics and impact on clinical outcomesArielle J. Medford, Aditya Bardia, Amy Comander et al.|Cancer Research|2024Cited by 1
Nectin-4 expression in primary breast cancer and associated clinical outcomes.Arielle J. Medford, Aditya Bardia, Andrzej Niemierko et al.|Journal of Clinical Oncology|2024Cited by 1
Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cellsAvanish Mishra, Shyamala Maheswaran, Rachel O. Abelman et al.|Proceedings of the National Academy of Sciences|2026Cited by 1